Facilitated By

San Antonio Medical Foundation

News

  • 'This is scientific censorship of the worst kind': The Trump administration reportedly froze the ...

    ... stop acquiring fetal tissue from California-based source Advanced Bioscience Resources (ABR), which had been supplying the fetal tissue for years.

  • Recon: Gilead Hires Roche's Pharma Head as New CEO

    ... Cancer at 2018 San Antonio Breast Cancer Symposium (SABCS) (Press); Zymeworks Submits Investigational New Drug (IND) Application for ZW49 ...

  • Scaleworks co-founder talks venture capital and what he looks for in a CEO

    Byrne sat down with the San Antonio Express-News at Scaleworks earlier ... If you're a biotech or energy company, you need venture capital for that.

  • Generon Presented Positive Phase III Results From a Double-Blind, Placebo Controlled-Clinical ...

    SHANGHAI--(BUSINESS WIRE)--Dec 8, 2018--Generon BioMed Holding ... announced today at the annual San Antonio Breast Cancer Symposium ...

  • Meridian Bioscience (VIVO) Shareholder Brown Capital Management Cut Its Stake by $5.16 Million ...

    Brown Capital Management Llc decreased its stake in Meridian Bioscience Inc ... Meridian Bioscience, Inc. (NASDAQ:VIVO) has risen 11.66% since ... at San Antonio Breast Cancer Symposium – Nasdaq” published on November 14 ...